Annual Drug Patent Expirations for ORBACTIV
Orbactiv is a drug marketed by Melinta Therap and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug.
This drug has ninety-eight patent family members in thirty-four countries.
The generic ingredient in ORBACTIV is oritavancin diphosphate. Two suppliers are listed for this compound. Additional details are available on the oritavancin diphosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com